233 related articles for article (PubMed ID: 23488990)
1. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.
Garg H; Kumar A; Garg V; Kumar M; Kumar R; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2013 Aug; 28(8):1361-7. PubMed ID: 23488990
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure.
Garg H; Kumar A; Garg V; Sharma P; Sharma BC; Sarin SK
Dig Liver Dis; 2012 Feb; 44(2):166-71. PubMed ID: 21978580
[TBL] [Abstract][Full Text] [Related]
3. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
[TBL] [Abstract][Full Text] [Related]
4. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic studies in acute-on-chronic liver failure.
Kumar A; Das K; Sharma P; Mehta V; Sharma BC; Sarin SK
Dig Dis Sci; 2009 Apr; 54(4):869-78. PubMed ID: 18688717
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
8. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
11. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
[TBL] [Abstract][Full Text] [Related]
12. Acute on chronic liver disease in children from the developing world: recognition and prognosis.
Jagadisan B; Srivastava A; Yachha SK; Poddar U
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):77-82. PubMed ID: 21691224
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
[TBL] [Abstract][Full Text] [Related]
14. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
Ruiz-del-Arbol L; Urman J; Fernández J; González M; Navasa M; Monescillo A; Albillos A; Jiménez W; Arroyo V
Hepatology; 2003 Nov; 38(5):1210-8. PubMed ID: 14578859
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone in outcome of patients with hepatitis B virus-related acute-on-chronic liver failure.
Chen JF; Wang KW; Zhang SQ; Lei ZY; Xie JQ; Zhu JY; Weng WZ; Gao ZL; Lin BL
J Gastroenterol Hepatol; 2014 Apr; 29(4):800-6. PubMed ID: 24224656
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
[TBL] [Abstract][Full Text] [Related]
17. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure.
Garg V; Garg H; Khan A; Trehanpati N; Kumar A; Sharma BC; Sakhuja P; Sarin SK
Gastroenterology; 2012 Mar; 142(3):505-512.e1. PubMed ID: 22119930
[TBL] [Abstract][Full Text] [Related]
20. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
